Home Cart Sign in  
Chemical Structure| 1239600-18-0 Chemical Structure| 1239600-18-0

Structure of LMT-28
CAS No.: 1239600-18-0

Chemical Structure| 1239600-18-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LMT-28 is an orally active IL-6 inhibitor that works by binding directly to gp130. It has low toxicity and selectively inhibits the phosphorylation of STAT3, JAK2, and gp130 induced by IL-6.

Synonyms: LMT-28

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of LMT-28

CAS No. :1239600-18-0
Formula : C17H29NO4
M.W : 311.42
SMILES Code : O=C1OC[C@@H](N1C([C@H]([C@@H](C(CCCCC)=C)O)C)=O)C(C)C
Synonyms :
LMT-28
MDL No. :MFCD30187587

Safety of LMT-28

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of LMT-28

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse embryonic osteoblasts (MC3T3-E1) 100 nM 4 hours LMT-28 downregulated the expression of RANKL through the JAK2/STAT3 signaling pathway in osteoblasts stimulated by LPS and AGEs. Mediators Inflamm. 2023 Jan 6;2023:9330439

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice OVA-induced allergic conjunctivitis model Ocular surface drops 1 μg/μL 3 times/day for at least 9 days To evaluate the therapeutic effect of LMT-28 on OVA-induced allergic conjunctivitis. Results showed that LMT-28 significantly alleviated ocular surface inflammation, reduced serum levels of IgE, IL-4, IL-5, and IL-13, and decreased the number of mast cells in conjunctival tissue. Invest Ophthalmol Vis Sci. 2023 Apr 3;64(4):5
Sprague-Dawley (SD) rats Type 2 diabetic rat model with peri-implantitis Gavage 0.23 mg/kg Once every 5 days for 2 weeks LMT-28 reduced bone resorption around implants with peri-implantitis, decreased the expression of IL-6 and RANKL, and decreased osteoclast activity in type 2 diabetic rats. Mediators Inflamm. 2023 Jan 6;2023:9330439

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.21mL

0.64mL

0.32mL

16.06mL

3.21mL

1.61mL

32.11mL

6.42mL

3.21mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories